Friday, 20 May 2016

Cocaine Dependence Treatment Market to be Driven by Introduction of Vaccines for Treatment

A new market research report by Transparency Market Research provides a detailed analysis of the global market for cocaine dependence treatment. The study emphasizes on the market overview, product segmentation, market drivers and restraints, current market trends, challenges and opportunities, major geographical segments, and competitive landscape of the market. The research report, titled “Cocaine Dependence Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020,” further includes the forecast figures and historical data of the market along with strategic recommendations and valued inputs so as to guide existing as well as new players in designing their business policies.


The growing youth population has been abusing cocaine in increasing numbers and the health effects of abusing it are quite severe. As a result, the demand for cocaine de-addiction has been gaining traction in recent years. In addition, the growing awareness regarding the ill-effects of cocaine abuse is further expected to fuel the growth of the global market for cocaine dependence treatment in the coming years. The introduction of vaccines for cocaine dependence treatment is considered as a potential opportunity for the major players in this market. However, the rigid regulatory approval process is hampering the growth of the market.   

On the basis of medication type, the global market for cocaine dependence treatment has been segmented into Vigabatrin, Gabapentin, N-acetylcysteine (NAC), Nocaine, Propanolol, Disulfiram, Baclofen, and Modafinil, whereas on the basis of treatment type, the global market for cocaine dependence treatment has been classified into intensive outpatient rehab, inpatient cocaine rehab, withdrawal treatment and detox centers, and addiction counseling and aftercare. The market share and estimates of each segment have been included in the research study.

The research study has further classified the global market for cocaine dependence treatment on the basis of geography into North America, Europe, Asia Pacific, and Rest of the World. Currently, North America accounts for the largest share in the overall market owing to the high number of cocaine users in this region. Even though more cocaine addiction cases are being reported in several developing economies, the bulk of cocaine is still being consumed in several parts of Europe and North America. The developing economies in South America, the Caribbean, and Central America are the potential markets for cocaine dependence treatments. As per the study, collectively these regions have approximately 3 million cocaine users.

Furthermore, the research study talks about the competitive landscape of the global market for cocaine dependence treatment, including the company overview, inception details, contact information, product portfolio, financial overview, business policies, SWOT analysis, and recent developments such as major mergers and acquisitions. The major players operating in the global market for cocaine dependence treatment include Pfizer Inc., Savant HWP, Inc., Lannett Company, Inc., and Catalyst Pharmaceutical Partners, Inc.

Full Research Report on Global Cocaine Dependence Treatment Market: 
http://www.transparencymarketresearch.com/cocaine-dependence-treatment.html

No comments:

Post a Comment